IL-6 Inhibition for Modulating Inflammation After Cardiac Arrest

NCT03863015 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Heart Arrest
Out-Of-Hospital Cardiac Arrest
Systemic Inflammatory Response Syndrome

Interventions

DRUG: Tocilizumab 20 Mg/mL Intravenous Solution
DRUG: isotonic saline

Sponsor

Christian Hassager